Formic Acid

Formic Acid

SCHEMBL30468942

O=CO.O=NC(=O)c1cccnc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
GAA P10253 2/20 0.53
APP P05067 1/20 0.53
HCAR3 P49019 1/20 0.53
HCAR2 Q8TDS4 1/20 0.53
F7 P08709 1/20 0.52
F3 P13726 1/20 0.52
SARM1 Q6SZW1 1/20 0.52
SIRT2 Q8IXJ6 1/20 0.52
SIRT6 Q8N6T7 1/20 0.52
SIRT1 Q96EB6 1/20 0.52
SIRT3 Q9NTG7 1/20 0.52
SIRT5 Q9NXA8 1/20 0.52
SIRT4 Q9Y6E7 1/20 0.52
HDAC1 Q13547 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
PLOD2 O00469 1/20 0.46
MAPT P10636 3/20 0.45
KDM4E B2RXH2 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL128527 0.93 ALDH1A1 (0.61) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL30202509 0.93 ALDH1A1 (0.61) ALDH1A1GAAAPPHCAR3HCAR2
Nitric Acid SCHEMBL29118937 0.83 ALDH1A1 (0.50) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL30690216 0.79 ALDH1A1 (0.84) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL2000039 0.79 ALDH1A1 (0.63) ALDH1A1GAAAPPHCAR3HCAR2
Formic Acid SCHEMBL27888254 0.78 ALDH1A1 (0.57) ALDH1A1GAAAPPHCAR3HCAR2
Niacinamide SCHEMBL2771125 0.78 F7 (0.85) ALDH1A1GAAAPPHCAR3HCAR2
Formic Acid SCHEMBL28800438 0.76 ALDH1A1 (0.60) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL4186314 0.76 GAA (0.59) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL27764010 0.76 ALDH1A1 (0.59) ALDH1A1GAAAPPHCAR3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203029-A1 NAPHTHYRIDINE COMPOUNDS AS INHIBITORS OF MER TYROSINE KINASE AND AXL TYROSINE KINASE EVOTEC (UK) LIMITED (GB) 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203029-A1 NAPHTHYRIDINE COMPOUNDS AS INHIBITORS OF MER TYROSINE KINASE AND AXL TYROSINE KINASE MERTK, AXL, TYRO3 ALDH1A1 3238/4885GAA 661/4885APP 689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.